Press Releases

13 February 2014 – Tate & Lyle PLC New Alliance with McNeil Nutritionals Tate & Lyle PLC announces today the latest phase of its 30-year Sucralose partnership with McNeil Nutritionals, LLC through the establishment of a renewed SPLENDA ® Alliance. The focus for the renewed partnership will be the...

Release of the Group Trading Statement for the three months ended 31 December 2015 shows the Group on track to deliver full year guidance.

Lars Frederiksen and Sybella Stanley appointed as Non-Executive Directors with effect from 1 April 2016.

Release of the trading update for the six months to 30 September 2015 shows the Group is performing in line with expectations.

McGill University announced as winners of Developing Solutions for Developing Countries Competition at Institute of Food Technologists Student Association.

K ai Nargolwala, a non-executive director of Tate & Lyle PLC (the "Company"), has informed the Company that he has been appointed as a non-executive director of Singapore Telecommunications Limited from 29 September 2006. This disclosure is made to comply with LR 9.6.14 R of the listing rules.

Tate & Lyle PLC announces the disposal of its 5% interest in Royal Swaziland Sugar Corporation Limited. The book value of the investment was £3m at 30 September 2001. The shares have been bought by Ingwenyama in trust for the Swazi nation acting through Tibiyo TakaNgwane.The disposal is another...

At the Annual General Meeting of Tate & Lyle PLC in London today, Sir David Lees, Chairman, made the following statement on current trading: There has been little overall change in trading conditions or in the outlook since the beginning of June, when I signed the Chairman’s Statement in the Annual...

Tate & Lyle PLC announces the appointment of Hoare Govett Limited as joint corporate broker to work alongside Citi.

Tate & Lyle PLC (“Tate & Lyle”) announces today it has signed an agreement for the sale of its EU Sugar Refining operations (“EUS”) to American Sugar Refining, Inc. The consideration is £211 million payable in cash, subject to closing adjustments for net cash and working capital, with the proceeds...